ReviewCureus2020

Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity.

Chetana Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.